cancer clinical trials in burlington, VT

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Kidney Cancer

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Vermont Cancer Center at University of Vermont
Burlington, Vermont 05405-0075

Colorectal Cancer

Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women

Fletcher Allen Health Care, Radiation Oncology
Burlington, Vermont 05401

Stage I Breast Cancer

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia, Myelodysplastic Syndromes

Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Esophageal Cancer

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Breast Cancer

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Breast Cancer

Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Prostate Cancer

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Prostate Cancer

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Lung Cancer

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Fletcher Allen Health Care-Medical Center
Burlington, Vermont 05401

Endometrial Cancer

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Lung Cancer

Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Neuroblastoma

Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone

The University of Vermont
Burlington, Vermont 05401

Multiple Myeloma

Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Lung Cancer, Radiation Toxicity

Patients With Advanced Non-Small Cell Lung Cancer

Fletcher Allen Health Care
Burlington, Vermont 05401

Non-Small Cell Lung Carcinoma

Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer

University of Vermont Cancer Center
Burlington, Vermont 05401

Breast Cancer, Carcinoma of the Breast

The Active After Cancer Trial (AACT)

Vermont Cancer Center
Burlington, Vermont 05401-3498

Breast Cancer, Colorectal Cancer

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

Vermont Cancer Center at University of Vermont
Burlington, Vermont 05405-0075

Chemotherapy-induced Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific

Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Lymphoma

Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia

Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

Fletcher Allen Health Care-Medical Center
Burlington, Vermont 05401

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer

Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Neuroblastoma

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Prostate Cancer

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia

Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer

Vermont Cancer Center at Fletcher Allen Health Care
Burlington, Vermont 05401

Thyroid Cancer

FTY720 in Patients With Primary Progressive Multiple Sclerosis

Fletcher Allen Health Care
Burlington, Vermont 05401

Primary Progressive Multiple Sclerosis

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

University of Vermont Office of Clinical Trials Res.
Burlington, Vermont 05404

Diffuse Large B-cell Lymphoma

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Fletcher Allen Health Care-Medical Center
Burlington, Vermont 05401

Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer

A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver

Vermont Cancer Center at University of Vermont
Burlington, Vermont 05405-0075

Metastatic Colorectal Cancer

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Endometrial Cancer, Fatigue, Neurotoxicity

Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Lymphoma

Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes

Vermont Cancer Center at University of Vermont
Burlington, Vermont 05405-0075

Bladder Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Leukemia, Liver Cancer, Lung Cancer, Pancreatic Cancer, Tobacco Use Disorder

Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

UVM/FAHC
Burlington, Vermont 05401

Neuroblastoma, Medulloblastoma, Relapse

Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia, Lymphoma

Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

Pfizer Investigational Site
Burlington, Vermont 05401-3456

Breast Cancer

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Fletcher Allen Health Care-Medical Center
Burlington, Vermont 05401

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Endometrial Cancer

Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia, Lymphoma

Collecting Tumor Samples From Patients With Gynecological Tumors

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Cancer

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific

Study of Kidney Tumors in Young Patients

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Kidney Cancer, Nonneoplastic Condition

Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms

Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Sarcoma

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Lung Cancer

Collecting and Storing Biological Samples From Patients With Ewing Sarcoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Sarcoma

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia

Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Lymphoma

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Neuroblastoma

Statins and Breast Cancer Biomarkers

Vermont Cancer Center
Burlington, Vermont 05401-3498

Breast Cancer

Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Brain and Central Nervous System Tumors

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Endometrial Cancer

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Vermont Cancer Center at Fletcher Allen Health Care
Burlington, Vermont 05401

Cancer

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Fletcher Allen Health Care-Medical Center
Burlington, Vermont 05401

Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Ovarian Cancer, Sarcoma

Study of Blood Samples From Newborns With Down Syndrome

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia

Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy

Fletcher Allen Health Care
Burlington, Vermont 05401

Nausea, Vomiting

Multicenter Hologic Tomosynthesis Study

Fletcher Allen Health Care
Burlington, Vermont 05401

Breast Cancer

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Fletcher Allen Health Care-Medical Center
Burlington, Vermont 05401

Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma

Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer

Fletcher Allen Health Care
Burlington, Vermont 05401

Head and Neck Neoplasms

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

Fletcher Allen Health Care
Burlington, Vermont 05401

Neoplasms, Constipation, Opioid-Related Disorders

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Leukemia

Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma

Fletcher Allen Health Care-Medical Center
Burlington, Vermont 05401

Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma

Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

University of Vermont/Vermont Cancer Center
Burlington, Vermont 05401

Pancreatic Cancer, Ductal Adrenocarcinoma, Exocrine Pancreatic Cancer

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

UVM/FAHC
Burlington, Vermont 05401

Neuroblastoma

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Lymphoma

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont 05401

Lymphoma